Capricor Therapeutics, Inc. (CAPR) vs Carlsmed, Inc. (CARL)
A side-by-side comparison of Capricor Therapeutics, Inc. and Carlsmed, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAPR
Capricor Therapeutics, Inc.
$7.73HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
CARL
Carlsmed, Inc.
$14.91HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
Total return — CAPR vs CARL
growth of $100 · dividends reinvested · last 1yCAPR +8.7% (+8.7%/yr)CARL +5.5% (+5.5%/yr)CAPR compounded faster over this window
CAPR CARL
CAPR vs CARL: by the numbers
- •CAPR is the larger company ($445M vs $405M market cap).
- •Both run net losses; CAPR's is the smaller (0.00% vs -57.42% net margin).
Metrics side by side
Valuation
| Metric | CAPR | CARL |
|---|---|---|
| P/S ratio | N/A | 6.40 |
| P/B ratio | 1.81 | 4.81 |
| EV / EBITDA | 0.44 | N/A |
Profitability
| Metric | CAPR | CARL |
|---|---|---|
| Gross margin | 0.00% | 76.63% |
| Operating margin | 0.00% | -61.09% |
| Net margin | 0.00% | -57.42% |
| ROE | -52.56% | -43.14% |
| ROIC | -40.25% | -36.54% |
Growth (annualized)
| Metric | CAPR | CARL |
|---|---|---|
| Total return CAGR (5Y) | 15.17% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.